Vicapsys Life Sciences (VICP) Short Interest Ratio & Short Volume $2.05 0.00 (0.00%) As of 02/21/2025 Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsSEC FilingsShort Interest Vicapsys Life Sciences Short Interest DataVicapsys Life Sciences (VICP) has a short interest of 100 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 65 shares to cover all short positions.Current Short Interest100 sharesPrevious Short Interest100 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$300.00Short Interest Ratio0.3 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares32,371,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume65 sharesToday's Volume Vs. Average0% Short Selling Vicapsys Life Sciences? Sign up to receive the latest short interest report for Vicapsys Life Sciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVICP Short Interest Over TimeVICP Days to Cover Over TimeVICP Percentage of Float Shorted Over Time Vicapsys Life Sciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/2025100 shares $300.00 No ChangeN/A0.3 $3.00 1/15/2025100 shares $150.00 No ChangeN/A1 $1.50 12/31/2024100 shares $0.00 No ChangeN/A0 $0.00 12/15/2024100 shares $0.00 No ChangeN/A0.5 $0.00 11/30/2024100 shares $151.00 No ChangeN/A0 $1.51 11/15/2024100 shares $151.00 No ChangeN/A0 $1.51 10/31/2024100 shares $151.00 No ChangeN/A0 $1.51 10/15/2024100 shares $151.00 No ChangeN/A0 $1.51 9/30/2024100 shares $151.00 No ChangeN/A0 $1.51 9/15/2024100 shares $151.00 No ChangeN/A0 $1.51 Get the Latest News and Ratings for VICP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vicapsys Life Sciences and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024100 shares $151.00 No ChangeN/A0 $1.51 8/15/2024100 shares $151.00 No ChangeN/A0 $1.51 7/31/2024100 shares $151.00 -66.7%N/A1 $1.51 7/15/2024300 shares $1,500.00 -85.7%N/A0.3 $5.00 6/30/20242,100 shares $14,700.00 No ChangeN/A1 $7.00 12/15/2022100 shares $100.00 No ChangeN/A0 $1.00 11/30/2022100 shares $100.00 No ChangeN/A0 $1.00 11/15/2022100 shares $100.00 No ChangeN/A0 $1.00 10/31/2022100 shares $100.00 No ChangeN/A0 $1.00 10/15/2022100 shares $100.00 No ChangeN/A0 $1.00 9/30/2022100 shares $100.00 No ChangeN/A1 $1.00 9/15/2022100 shares $100.00 No ChangeN/A0 $1.00 8/31/2022100 shares $100.00 -50.0%N/A1 $1.00 8/15/2022200 shares $504.00 No ChangeN/A2 $2.52 7/31/2022200 shares $504.00 No ChangeN/A2 $2.52 7/15/2022200 shares $504.00 No ChangeN/A0 $2.52 6/30/2022200 shares $504.00 No ChangeN/A0 $2.52 6/15/2022200 shares $504.00 No ChangeN/A2 $2.52 5/31/2022200 shares $504.00 No ChangeN/A2 $2.52 5/15/2022200 shares $504.00 No ChangeN/A2 $2.52 4/30/2022200 shares $504.00 No ChangeN/A0.7 $2.52 4/15/2022200 shares $520.00 No ChangeN/A2 $2.60 3/31/2022200 shares $520.00 No ChangeN/A0 $2.60 3/15/2022200 shares $520.00 No ChangeN/A0 $2.60 2/28/2022200 shares $520.00 No ChangeN/A0 $2.60 2/15/2022200 shares $520.00 No ChangeN/A2 $2.60 1/31/2022200 shares $1,000.00 No ChangeN/A0.7 $5.00 VICP Short Interest - Frequently Asked Questions What is Vicapsys Life Sciences' current short interest? Short interest is the volume of Vicapsys Life Sciences shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 100 shares of VICP short. Learn More on Vicapsys Life Sciences' current short interest. How does Vicapsys Life Sciences' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vicapsys Life Sciences: Benitec Biopharma Inc. (0.55%), Heron Therapeutics, Inc. (20.28%), AC Immune SA (1.71%), Atea Pharmaceuticals, Inc. (4.01%), Acelyrin, Inc. (8.09%), Eledon Pharmaceuticals, Inc. (2.04%), Neurogene Inc. (11.44%), Y-mAbs Therapeutics, Inc. (10.90%), Tango Therapeutics, Inc. (10.98%), Bright Minds Biosciences Inc. (2.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Vicapsys Life Sciences stock? Short selling VICP is an investing strategy that aims to generate trading profit from Vicapsys Life Sciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vicapsys Life Sciences? A short squeeze for Vicapsys Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VICP, which in turn drives the price of the stock up even further. How often is Vicapsys Life Sciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VICP, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies Benitec Biopharma Short Squeeze Heron Therapeutics Short Squeeze AC Immune Short Squeeze Atea Pharmaceuticals Short Squeeze Acelyrin Short Squeeze Eledon Pharmaceuticals Short Squeeze Neurogene Short Squeeze Y-mAbs Therapeutics Short Squeeze Tango Therapeutics Short Squeeze Bright Minds Biosciences Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:VICP) was last updated on 2/24/2025 by MarketBeat.com Staff From Our PartnersIgnore Fox Business’s “man who calls it all” at your perilThis is the biggest AI investment story you’ve never been told… and people who invest before March 19 could st...The Oxford Club | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicapsys Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vicapsys Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.